A phase 1 study of nevanimibe HCl, a novel adrenal-specific sterol O-acyltransferase 1 (SOAT1) inhibitor, in adrenocortical carcinoma
David C. Smith, Matthias Kroiß, Electron Kebebew, Mouhammed Amir Habra, Rashmi Chugh, Bryan J. Schneider, Martin Faßnacht, Pegah Jafarinasabian, M. Marian Ijzerman, Vivian Lin, Pharis Mohideen, Aung Naing
Topics & Concepts
MedicineAdrenocortical carcinomaMitotaneGastroenterologyInternal medicineVomitingAdverse effectResponse Evaluation Criteria in Solid TumorsAdrenal insufficiencyChemotherapyPhases of clinical researchEndocrinologyPharmacologyAdrenal and Paraganglionic TumorsHormonal Regulation and HypertensionCancer, Hypoxia, and Metabolism